A ARS PHARMACEUTICALS INC
| Market Cap | $824.17M |
| P/E Ratio | — |
| Forward P/E | -11.64 |
| Dividend Yield | — |
| Beta | 0.93 |
| 52W Range | $6.73 - $18.35 |
| # Hedge Funds | 1 |
| Sector | Healthcare |
| Industry | Biotechnology |
Hedge Fund Ownership
| Investor 1 | % of Portfolio Weight of this stock in the investor's portfolio | Value Total dollar value of the position | Shares Number of shares held | Activity Portfolio change type: New, Increased, Decreased, or Sold |
|---|---|---|---|---|
| Daniel Loeb Third Point LLC | 0.09% | $6.48M | 556,237 | Buy |
Insider Trading
| Insider Name of the company insider who made the trade 3 | Type Purchase (buy) or Sale (sell) | Shares Number of shares traded | Price Price per share at time of transaction | Value Total dollar value of the transaction | Trade Date Date the transaction was executed | Filing Date Date the SEC filing was submitted |
|---|---|---|---|---|---|---|
| Dorsey BrianChief Operating Officer | Sale | 21,828 | $8.71 | $190.05K | 13 Nov 2025 | 14 Nov 2025 |
| Chakma JustinChief Business Officer | Sale | 30,000 | $8.91 | $267.36K | 12 Nov 2025 | 14 Nov 2025 |
| Chakma JustinChief Business Officer | Sale | 136,380 | $8.86 | $1.21M | 12 Nov 2025 | 14 Nov 2025 |
Frequently Asked Questions
What is SPRY stock price today?
ARS PHARMACEUTICALS INC (SPRY) is currently trading at $8.30. The stock has a 52-week range of $6.73 to $18.35 and a market capitalization of $824.17M.
Is SPRY a good stock to buy in 2026?
ARS PHARMACEUTICALS INC has a P/E ratio of N/A (forward P/E: N/A), a dividend yield of none, and 1-year performance of -38.1%. 1 hedge funds hold this stock. Review the fundamentals and ownership data above to make an informed decision.
Are insiders buying or selling SPRY stock?
There have been 3 insider transactions for SPRY in recent months. Insider buys can signal management confidence, while sales may reflect diversification or personal financial planning. Check the Insider Trading section above for details.
How has SPRY stock performed over the past year?
ARS PHARMACEUTICALS INC (SPRY) has returned -38.1% over the past 12 months. The stock traded between $6.73 and $18.35 during this period, and is currently at $8.30.
Which hedge funds own SPRY (ARS PHARMACEUTICALS INC)?
1 tracked hedge funds currently hold SPRY in their portfolios as of the latest 13F filings. See the ownership table above for the complete list.
What is SPRY's market cap and valuation?
ARS PHARMACEUTICALS INC (SPRY) has a market capitalization of $824.17M. The trailing P/E ratio is N/A and forward P/E is N/A. The stock is classified in the Healthcare sector.
What is SPRY's revenue and profitability?
ARS PHARMACEUTICALS INC reported revenue of $84.28M with net income of N/A and a profit margin of N/A. The stock has a beta of 0.93.
What sector is SPRY in and who are its biggest institutional holders?
ARS PHARMACEUTICALS INC (SPRY) operates in the Healthcare sector. It is held by 1 tracked hedge funds. See the ownership table above for the complete list.